Changes in cytosolic and membrane TNF inhibitory protein-B1 (TIP-B1) levels associated with protection from TNF-induced cytotoxicity.
Henn
A D
AD
Department of Pharmacology and Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
Berleth
E S
ES
Mihich
E
E
Ehrke
M J
MJ
D048868:Adaptor Proteins, Signal Transducing; D002458:Cell Fractionation; D003513:Cycloheximide / Q000494:pharmacology; D020405:Dermis / Q000166:cytology; D005347:Fibroblasts / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D015151:Immunoblotting; D047908:Intracellular Signaling Peptides and Proteins; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011506:Proteins / Q000235:genetics / Q000378:metabolism*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D048868:Adaptor Proteins, Signal Transducing; D047908:Intracellular Signaling Peptides and Proteins; D011500:Protein Synthesis Inhibitors; D011506:Proteins; C400565:SH3BGRL3 protein, human; D014409:Tumor Necrosis Factor-alpha; D003513:Cycloheximide